Vivesto
0.08 SEK
+0.50 %
Less than 1K followers
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vivesto
EV/S
Median 2019-2022
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 3.95 | 3.59 | 2.28 | 0.38 | 0.35 | 0.25 | 0.12 |
| Shares | 311.9 | 515.1 | 515.1 | 618.2 | 618.2 | 618.2 | 618.2 |
| Market cap | 1,232.4 | 1,847.3 | 1,176.1 | 233.5 | 219.3 | 156.0 | 72.6 |
| Enterprise value | 1,255.7 | 1,501.0 | 1,089.2 | 99.2 | 142.2 | 123.7 | - |
| EV/S | 634.2 | 7.4 | 41.6 | 97.2 | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 2.91 | 2.23 | 2.14 | 0.45 | 1.11 | 0.99 | 0.58 |
| P/S | 622.4 | 9.2 | 44.9 | 228.9 | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 65.6 % | 81.7 % | 92.5 % | 94.4 % | 89.6 % | 91.6 % | 83.6 % |
| Gearing ratio | 32.9 % | 10.7 % | 1.9 % | 1.6 % | - | - | 10.4 % |